You're Reacting to Cleaning Products. Your Genes May Be Why.

GSTM1 encodes one of your most important detoxification enzymes. Its job is to attach glutathione (your body’s primary antioxidant and detox molecule) to toxic compounds so they can be eliminated. It handles a broad range of toxins: pesticides, solvents, heavy metals, and the volatile organic compounds released by cleaning products.

The problem is simple: roughly 50% of the population carries a GSTM1 deletion. You either have two working copies, one copy, or none at all. If you have the null genotype (no working copies), you’re missing this entire enzyme. That doesn’t mean you’re broken; it means you’re using a backup pathway that’s slower and less efficient.

When you’re exposed to bleach, ammonia, or synthetic fragrances, your body has to work harder to clear them. The molecules linger longer in your bloodstream and tissues. Your head pounds. Your eyes water. Your throat tightens. Over days and weeks, these compounds accumulate and trigger inflammation.

GSTP1 is another glutathione transferase, but it specializes in handling oxidative stress byproducts and electrophilic pollutants. When cleaning products release volatile organic compounds or when your body breaks down other toxins, GSTP1 conjugates those byproducts so they can exit your system.

The Ile105Val variant in GSTP1 (carried by roughly 35-40% of the population) reduces enzyme activity. You still have the enzyme, but it works slower and less efficiently. The Val allele means your glutathione conjugation capacity is compromised.

Inhale a cloud of bleach fumes, and your cells generate oxidative stress. GSTP1 is supposed to grab those reactive molecules before they damage your mitochondria and DNA. If your GSTP1 is sluggish, that damage accumulates. You feel brain fog, fatigue, and increased sensitivity to future exposures.

CYP1A2 is a Phase I detoxification enzyme. It takes large, lipid-soluble molecules (like polycyclic aromatic hydrocarbons in cleaning product fumes) and begins breaking them down into smaller pieces that Phase II enzymes can handle. It’s the first step in a relay race where the baton gets passed from CYP1A2 to GSTM1 or GSTP1.

The Ile462Val variant in CYP1A2 affects how fast this first step works. Roughly 5-10% of people carry this variant. If you have it, your Phase I machinery runs differently, which changes how efficiently the relay works downstream. You’re not necessarily slow; you’re just different.

When you breathe in cleaning product fumes, CYP1A2 springs into action. If your variant means you process compounds more slowly or differently, the timing of when Phase II kicks in gets out of sync. Intermediate metabolites accumulate. Your body feels overloaded even by normal exposures.

MTHFR converts folate into the active form your cells need for methylation: the process by which your body adds a methyl group to toxins so they can be eliminated. MTHFR is upstream of everything. Glutathione synthesis depends on methylation. Heavy metal binding depends on methylation. Without efficient MTHFR function, your detox pathways starve for raw materials.

The C677T variant in MTHFR, present in roughly 40% of the European ancestry population, reduces enzyme activity by 35-40%. You’re producing less of the active folate form, so glutathione production slows and heavy metal clearance weakens. If you have two copies (homozygous), the impact is more pronounced.

You breathe in cleaning product chemicals, and your body is simultaneously trying to clear any metals or persistent compounds from prior exposures. MTHFR is the bottleneck. Glutathione doesn’t get made fast enough. Heavy metals don’t get bound and excreted. You feel increasingly reactive and increasingly toxic, even from smaller exposures.

SOD2 is your mitochondrial antioxidant. It neutralizes superoxide radicals, the most common free radical your mitochondria generate during energy production. When you’re exposed to toxic chemicals, your mitochondria get overwhelmed and produce even more radicals. SOD2 is your primary defense against that cascade.

The Val16Ala variant in SOD2 (homozygous in roughly 40% of people with European ancestry) reduces the enzyme’s ability to accumulate in the mitochondrial matrix where it’s needed most. Your antioxidant defense is weaker, so oxidative stress accumulates faster during toxic exposures. Your mitochondria get damaged, and you feel the downstream effects as fatigue, brain fog, and systemic inflammation.

Inhale bleach fumes, and your mitochondria generate a burst of free radicals as they struggle to cope. If your SOD2 is weak, those radicals damage mitochondrial DNA and proteins. Your energy production crashes. You feel exhausted and toxic after even brief exposures.

NQO1 is a Phase II enzyme that specializes in detoxifying benzene, quinones, and other highly reactive compounds. Some cleaning products release benzene and benzene derivatives; others generate quinone-like molecules during oxidation. NQO1 is the enzyme that neutralizes those specific threats.

The Pro187Ser variant in NQO1 (present in 4-20% of people depending on ancestry) includes a null genotype where the enzyme is completely inactive. If you have the null variant, you have zero capacity to clear benzene and quinone-type compounds. You’re entirely dependent on less efficient backup pathways.

You use a product with benzene derivatives or your environment generates quinones from oxidative reactions (especially bleach mixed with other compounds). Your body has no primary pathway to handle them. Those molecules linger in your system, binding to tissues and accumulating. You feel immediate and severe reactions to certain products.